Rudra Narayan Swain, Assistant Professor Department of Clinical Hematology at SUM Hospital MD Medicine, shared a post on X:
“Our latest publication in Hematological Oncology.
A meta-analysis of 568 older adults with classical Hodgkin lymphoma.
Nivolumab-based frontline therapy may offer better efficacy and tolerability than BV-based approaches.
Grateful to Charanpreet Singh and all co-authors PGI Clinical Hematology and Medical Oncology, Gaurav Prakash, Pankaj Malhotra.”
Title: Efficacy and Safety of Novel-Agent–Based Front-Line Therapy in Older Adults Aged ≥ 60 Years With Classic Hodgkin Lymphoma: A Systematic Review and Meta-Analysis
Authors: Rudra Narayan Swain, Charanpreet Singh, Aditya Jandial, Arihant Jain, Alka Khadwal, Pankaj Malhotra, Gaurav Prakash
Other articles featuring Charanpreet Singh on OncoDaily.